Literature DB >> 5285946

Vaccination of adults with Wistar RA 27/3 rubella vaccine.

D S Freestone, J Prydie, S G Smith, G Laurence.   

Abstract

Thirty-three adults were vaccinated subcutaneously with Wistar RA. 27/3 (live attenuated) rubella vaccine at the Wellcome Research Laboratories, Beckenham. All subjects with pre-vaccination haemagglutinating-inhibiting antibody titres of 1/20 or less and three of seven subjects with pre-vaccination titres of 1/40 showed at least fourfold rises of titre. Reactions encountered were mild and of short duration.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5285946      PMCID： PMC2130909          DOI： 10.1017/s0022172400021720

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


  11 in total

1.  The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination.

Authors:  J J Mann; R D Rossen; J R Lehrich; J A Kasel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

2.  A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood.

Authors:  S A Plotkin; D J Bechtel; W D Sedwick
Journal:  Am J Epidemiol       Date:  1968-11       Impact factor: 4.897

3.  Removal by heparin-MnCl2 of nonspecific rubella hemagglutinin serum inhibitor.

Authors:  H A Feldman
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

4.  Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus.

Authors:  S A Plotkin; D Cornfeld; T H Ingalls
Journal:  Am J Dis Child       Date:  1965-10

5.  Effect of live measles vaccine on the platelet count.

Authors:  F A Oski; J L Naiman
Journal:  N Engl J Med       Date:  1966-08-18       Impact factor: 91.245

6.  Diagnosis and management: congenital rubella.

Authors:  L Z Cooper; S Krugman
Journal:  Pediatrics       Date:  1966-02       Impact factor: 7.124

7.  A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion.

Authors:  S A Plotkin; J Farquhar; M Katz; T H Ingalls
Journal:  Am J Epidemiol       Date:  1967-09       Impact factor: 4.897

8.  [The use of pigeon eruthrocytes in the hemagglutination inhibition test for rubella].

Authors:  J Peetermans; C Huygelen
Journal:  Presse Med       Date:  1967-10-21       Impact factor: 1.228

9.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

10.  Clinical and laboratory studies with rubella vaccines in adults.

Authors:  J A Dudgeon; W C Marshall; C S Peckham; G T Hawkins
Journal:  Br Med J       Date:  1969-02-01
View more
  8 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Programmes for the prevention of rubella during pregnancy by active immunization.

Authors:  D S Freestone
Journal:  Br J Prev Soc Med       Date:  1974-11

3.  Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Authors:  M Lalla; T Vesikari; M Virolainen
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

4.  Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.

Authors:  A J Tingle; M Allen; R E Petty; G D Kettyls; J K Chantler
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

5.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

Review 6.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 7.  Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV.

Authors:  Sarah Wilmschen; Joern E Schmitz; Janine Kimpel
Journal:  Vaccines (Basel)       Date:  2019-09-19

Review 8.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.